本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

8.91
-0.0050-0.06%
成交量:22.72万
成交额:202.13万
市值:6.65亿
市盈率:-15.94
高:9.07
开:8.70
低:8.69
收:8.91
52周最高:9.55
52周最低:2.54
股本:7,468.19万
流通股本:5,735.63万
量比:0.68
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5587
每股收益(LYR):-1.0214
净资产收益率:-35.82%
总资产收益率:-34.87%
市净率:9.27
市盈率(LYR):-8.72

数据加载中...

2021/09/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/02

重要事件披露

8-K - Current report
2021/08/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/15

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/22

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals